Actively Recruiting
Prospective Placebo-Controlled Trial of Intramuscular Steroid Administration for the Treatment of Unexplained Chronic Cough
Led by Medical University of South Carolina · Updated on 2025-07-14
40
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating whether injecting steroids into the muscle can effectively treat unexplained chronic cough, a condition where the cause of persistent cough is unknown. This trial is designed as a prospective, placebo-controlled, single-blind, randomized clinical study comparing steroid injections to placebo. The study aims to find out if these injections improve symptoms by measuring patient responses, cough-specific questionnaires, and symptom severity scores, while also documenting any side effects. Participants will be randomly assigned to receive either a steroid injection called Triamcinolone Acetonide or a saline injection into the deltoid muscle of the arm. The treatment is given as a one-time injection in the deltoid muscle, and the study will compare the outcomes between the two groups to see if steroid injections provide significant relief. This approach may offer a more accessible treatment option than nerve injections typically done by specialists. During the study, participants will be assessed over four weeks using the Leicester Cough Questionnaire, a visual analog scale for symptom severity, and a simple yes/no measure of symptom improvement. Researchers will carefully monitor for any adverse reactions. The total participation time includes the initial injection and follow-up evaluations over a one-month period to assess treatment effects and safety.
CONDITIONS
Brief Title
Efficacy of Intramuscular Steroid Injection for Chronic Cough.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- History consistent with chronic unexplained or refractory cough
- Age 18 years or older
You will not qualify if you...
- Current smokers
- Uncontrolled diabetes (A1c > 7%)
- Patients on ACE inhibitors or Angiotensin II receptor blockers (ARBs)
- Abnormal pulmonary function testing (PFTs) since start of the cough
- Patients with uncontrolled obstructive sleep apnea
- Abnormal chest X-ray within past 6 months
- Uncontrolled reflux
- Prior superior laryngeal nerve injection
- Current neuromodulating medication use for chronic cough*
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Single injection with follow-up lasting up to 4 weeks
Participants receive intramuscular injections of either steroid medication or placebo in the deltoid muscle to evaluate the effect on chronic cough.
1 baseline injection visit and 1 follow-up visit
Trial Site Locations
Total: 1 location
1
Medical University of South Carolina
Charleston, South Carolina, United States, 29403
Actively Recruiting
Research Team
K
Kirsten Meenan
L
Lauren Howser
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here